These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

206 related articles for article (PubMed ID: 18688237)

  • 1. The London Agreement and the future of parallel imports.
    Muir J
    Nat Biotechnol; 2008 Aug; 26(8):877-9. PubMed ID: 18688237
    [No Abstract]   [Full Text] [Related]  

  • 2. Pricing increases for cancer drugs sparks investigation.
    Venkatesan P
    Lancet Oncol; 2017 Jul; 18(7):e372. PubMed ID: 28552213
    [No Abstract]   [Full Text] [Related]  

  • 3. Parallel imports and the pricing of pharmaceutical products: evidence from the European Union.
    Ganslandt M; Maskus KE
    J Health Econ; 2004 Sep; 23(5):1035-57. PubMed ID: 15353192
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Patent nonsense: evidence tells of an industry out of social control.
    Mintzberg H
    CMAJ; 2006 Aug; 175(4):374. PubMed ID: 16908900
    [No Abstract]   [Full Text] [Related]  

  • 5. [Drug industry in India is threatened by free trade agreement].
    Jeppsson A
    Lakartidningen; 2009 Oct 7-13; 106(41):2589. PubMed ID: 19927922
    [No Abstract]   [Full Text] [Related]  

  • 6. Striking the right balance between innovation and drug price competition: putting the Hatch-Waxman Act into perspective.
    Deal JB
    Food Drug Law J; 1999; 54(2):185-6. PubMed ID: 11759712
    [No Abstract]   [Full Text] [Related]  

  • 7. Pricing and welfare implications of parallel imports in the pharmaceutical industry.
    Jelovac I; Bordoy C
    Int J Health Care Finance Econ; 2005 Mar; 5(1):5-21. PubMed ID: 15714261
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Big pharma swallows biotech's pride.
    Huggett B
    Nat Biotechnol; 2008 Sep; 26(9):955-6. PubMed ID: 18779785
    [No Abstract]   [Full Text] [Related]  

  • 9. [Discount for only one drug of the same group leads to impaired health care quality].
    Bergström R
    Lakartidningen; 2006 Feb 8-14; 103(6):387-8; discussion 388. PubMed ID: 16536044
    [No Abstract]   [Full Text] [Related]  

  • 10. Gray marketing of pharmaceuticals.
    Chaudhry PE; Walsh MG
    J Health Care Mark; 1995; 15(3):18-22. PubMed ID: 10172516
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Do manufacturers of brand-name drugs engage in price competition? An analysis of introductory prices.
    Lexchin J
    CMAJ; 2006 Apr; 174(8):1120-1. PubMed ID: 16606961
    [No Abstract]   [Full Text] [Related]  

  • 12. The impact of generic substitution on price competition in Finland.
    Aalto-Setälä V
    Eur J Health Econ; 2008 May; 9(2):185-91. PubMed ID: 17508226
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Merck wipes Serono off Swiss biotech map.
    Urquhart L
    Nat Biotechnol; 2006 Nov; 24(11):1303. PubMed ID: 17093457
    [No Abstract]   [Full Text] [Related]  

  • 14. The Future of the Pharmaceutical Industry: Beyond Government-Granted Monopolies.
    Baker D
    J Law Med Ethics; 2021; 49(1):25-29. PubMed ID: 33966644
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sales from licensed and acquired products to increase by 2013.
    Goodman M
    Nat Rev Drug Discov; 2009 Jun; 8(6):443. PubMed ID: 19483704
    [No Abstract]   [Full Text] [Related]  

  • 16. Folly or volley? Will a dollar $4 pill finally open the healthcare market to competitive pricing?
    Sturm AC
    Healthc Financ Manage; 2006 Nov; 60(11):120-2. PubMed ID: 17094287
    [No Abstract]   [Full Text] [Related]  

  • 17. The pharmaceutical industry--to whom is it accountable?
    Rightor N
    N Engl J Med; 2000 Nov; 343(19):1416; discussion 1417. PubMed ID: 11183882
    [No Abstract]   [Full Text] [Related]  

  • 18. [Patients, patents and profits].
    Haug C
    Tidsskr Nor Laegeforen; 2007 Nov; 127(22):2921. PubMed ID: 18026234
    [No Abstract]   [Full Text] [Related]  

  • 19. [Drug industry's misuse of patents must be prevented].
    Magnusson PA
    Lakartidningen; 2008 Feb 20-26; 105(8):555. PubMed ID: 18363299
    [No Abstract]   [Full Text] [Related]  

  • 20. A new approach to drug development.
    Brown S
    N Engl J Med; 2006 Nov; 355(19):2045; author reply 2046. PubMed ID: 17099948
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.